Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

MERIDIAN, ID, UNITED STATES, February 11, 2026 /EINPresswire.com/ -- Raising Awareness, Educating Communities, and ...

The gadolinium market in Spain is expected to grow at a CAGR of 3.9% by 2034. Spain's leadership in medical tourism is supported by a reputable private healthcare sector, which attracts advanced ...

Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function. The Food and Drug Administration (FDA) announced a new class warning and safety ...

After a nearly 2-year study, the US Food and Drug Administration (FDA) has not found any evidence of adverse events from the brain's retention of gadolinium after MRI that uses gadolinium-based ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Some of these studies evaluated GBCA use for durations >1 year and showed that gadolinium is retained in organs such as the brain, bones, and skin. After evaluating the risk of brain deposits with ...

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...

A new study has shown that artificial intelligence could be used to dramatically reduce the amount of gadolinium used in MRI scans. The findings, which are being presented today at the annual meeting ...

A small but concerning number of women are exposed to a commonly used MRI contrast agent early in their pregnancy, likely before many of them are aware that they're pregnant, according to a study ...

On Thursday, a law firm announced it was representing Chuck Norris in a suit against three different companies for $10 million in damages. Norris and his wife, Gena, claim that she has gadolinium ...

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, use of gadolinium-enhanced magnetic resonance imaging (MRI) in shoulders of patients with polymyalgia ...